APOE and Hypercholesterolemia: Thus, genetic modifications, such as low-density lipoprotein (LDL) receptor deficient (LDLR−/−) and apolipoprotein E knockout (ApoE−/−), have been applied to induce hypercholesterolemia in mice8–12.